Form 4: Senseonics Holdings Director Francine Kaufman Reports Stock Transaction
SEC Form 4 Filing
Francine Kaufman, a director and Chief Medical Officer of Senseonics Holdings, Inc., reported a transaction involving the withholding of shares to cover tax obligations.
Summary
- On May 15, 2024, Francine Kaufman, a Director and Chief Medical Officer of Senseonics Holdings, Inc., had shares withheld to cover withholding tax obligations upon the vesting of restricted stock units.
- A total of 1,404,878 shares of common stock are beneficially owned following the reported transaction.
- 53,923 shares were disposed of to cover the tax obligations.
Sentiment
Score: 5
Explanation: This is a neutral event related to tax obligations, not indicative of positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common occurrences in publicly traded companies. It provides transparency into the actions of company executives and directors regarding their holdings of the company's stock.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine adjustment of share ownership due to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of stock transaction (shares withheld for tax obligations) |
| 05/17/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.